Collaboration between Medtronic and PrediSurge

PrediSurge announces a collaboration with Medtronic to bring PrediSurge to customers who have chosen to use Medtronic’s industry leading EndurantTM stent graft for their patients.

‍

Introduction

After 15 years of research and evidence-driven scientific development, PrediSurge has developed a unique AI-powered digital twin technology, designed to evaluate complication risks preoperatively. PrediSurge’s technology, in conjunction with Medtronic’s Endurant stent graft, powers the SmartPlan Pro service, leveraging the strength of both parties to enhance aortic procedure planning. This service combines the software developed by PrediSurge and the hardware and sizing & planning expertise from Medtronic, aiming to support the choice of intervention strategy by providing patient-centric quantitative analysis, such as a risk of endoleaks.

‍

AI - Powered Digital Twin Technology

The digital twin technology developed by PrediSurge enables the creation of patient- specific virtual deployments of the stent graft. Simulation of different intervention scenarios enables physicians to assess complication risks and supports the selection of the best strategy for a given patient. This collaboration will enable Medtronic to expand its portfolio of digital solutions and PrediSurge to continue its expansion and offer its software across Europe.

‍